159 related articles for article (PubMed ID: 2200214)
1. Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer.
Rowley S; Newbold KM; Gearty J; Keighley MR; Donovan IA; Neoptolemos JP
World J Surg; 1990; 14(4):545-50; discussion 551. PubMed ID: 2200214
[TBL] [Abstract][Full Text] [Related]
2. Use of the OM-11-906 monoclonal antibody for determining p62 c-myc expression by flow cytometry in relation to prognosis in colorectal cancer.
Rowley S; Carpenter R; Newbold KM; Gearty J; Keighley MR; Donovan IA; Neoptolemos JP
Eur J Surg Oncol; 1991 Aug; 17(4):370-8. PubMed ID: 1874294
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy, c-myc oncoprotein p62 and v-H-ras oncoprotein p21 in colorectal carcinoma.
Teranishi T; Matsumoto K; Ishijima N; Miura T; Suzuki H
Surg Today; 1993; 23(1):89-91. PubMed ID: 8461612
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of ploidy of primary tumour and nodal secondaries in colorectal cancers.
Zoras OI; Curti G; Cooke TG; Vlachonikolis IG; Forster G; McArdle CS; Stanton PD
Surg Oncol; 1994 Dec; 3(6):345-9. PubMed ID: 7773451
[TBL] [Abstract][Full Text] [Related]
5. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry.
Albe X; Vassilakos P; Helfer-Guarnori K; Givel JC; de Quay N; Suardet L; Eliason JF; Odartchenko N
Cancer; 1990 Sep; 66(6):1168-75. PubMed ID: 2400968
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma.
Eminović-Behrem S; Trobonjaca Z; Petrovecki M; Dobi-Babić R; Dujmović M; Jonjić N
Croat Med J; 2000 Jun; 41(2):154-8. PubMed ID: 10853043
[TBL] [Abstract][Full Text] [Related]
7. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma.
Purdie CA; Piris J
Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056
[TBL] [Abstract][Full Text] [Related]
8. The prognostic role of the DNA ploidy pattern in colorectal cancer analysis using paraffin-embedded tissue by an improved method.
Yamazoe Y; Maetani S; Nishikawa T; Onodera H; Tobe T; Imamura M
Surg Today; 1994; 24(1):30-6. PubMed ID: 8054772
[TBL] [Abstract][Full Text] [Related]
9. DNA quantification in colorectal carcinoma using flow and image analysis cytometry.
Fausel RE; Burleigh W; Kaminsky DB
Anal Quant Cytol Histol; 1990 Feb; 12(1):21-7. PubMed ID: 2405870
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer.
Salud A; Porcel JM; Raikundalia B; Camplejohn RS; Taub NA
J Surg Oncol; 1999 Nov; 72(3):167-74. PubMed ID: 10562364
[TBL] [Abstract][Full Text] [Related]
11. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of flow cytometric analysis of DNA content in colorectal cancer: a prospective study.
Tomoda H; Kakeji Y; Furusawa M
J Surg Oncol; 1993 Jul; 53(3):144-8. PubMed ID: 8331935
[TBL] [Abstract][Full Text] [Related]
13. ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma.
Sun XF; Wingren S; Carstensen JM; Stål O; Hatschek T; Boeryd B; Nordenskjöld B; Zhang H
Eur J Cancer; 1991; 27(12):1646-9. PubMed ID: 1782077
[TBL] [Abstract][Full Text] [Related]
14. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
15. Colorectal carcinoma associated with ulcerative colitis: a study of prognostic indicators.
Heimann TM; Oh SC; Martinelli G; Szporn A; Luppescu N; Lembo CA; Kurtz RJ; Fasy TM; Greenstein AJ
Am J Surg; 1992 Jul; 164(1):13-7. PubMed ID: 1626600
[TBL] [Abstract][Full Text] [Related]
16. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
[TBL] [Abstract][Full Text] [Related]
17. A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer.
Jones DJ; Ghosh AK; Moore M; Schofield PF
Br J Cancer; 1987 Dec; 56(6):779-83. PubMed ID: 3325094
[TBL] [Abstract][Full Text] [Related]
18. c-myc oncogene product expression and prognosis in operable breast cancer.
Locker AP; Dowle CS; Ellis IO; Elston CW; Blamey RW; Sikora K; Evan G; Robins RA
Br J Cancer; 1989 Nov; 60(5):669-72. PubMed ID: 2679850
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of p53 expression and DNA ploidy pattern in colorectal cancer].
Nakamura T; Hishiki S; Baba S
Gan To Kagaku Ryoho; 1993 Apr; 20(6):780-3. PubMed ID: 8489286
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.
Bocquillon PG; Daver A; Page M; Dalifard I; Chassevent A; Cellier P; Bertrand G; Larra F; George P; Chabrun B
Bull Cancer; 1989; 76(3):291-300. PubMed ID: 2736315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
